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Abstract
Introduction: Unexplained anaemia is a rare mode of presentation for prolactinoma. We describe a case of a man,
with chronic anaemia ascribed to old age. Six years later, he was evaluated and diagnosed with a prolactinoma
and resultant osteoporosis. Prolactinoma in old people may present insidiously with chronic anaemia and
osteoporosis with or without sexual dysfunction.
Case presentation: We describe the case of a 70-year-old Caucasian man who presented with mild anaemia and
tiredness. His anaemia was investigated and ascribed to senescence. Endocrine causes were not considered or
tested for. Six years later, he was again referred. Reassessment and direct questioning revealed long-standing
sexual dysfunction. It was also discovered that our patient had fractured his radius twice, with minor trauma,
during the preceding year. His serum prolactin was massively increased and a magnetic resonance imaging (MRI)
scan of the head demonstrated a pituitary mass consistent with a prolactinoma. Dual X-ray absorptiometry
revealed osteoporosis. Treatment of the prolactinoma led to a reduction in his serum prolactin with a rise in his
haemoglobin to normal levels. This suggested that the prolactinoma was present during the initial presentation
and was the cause of his anaemia.
Conclusion: This case highlights the importance of fully evaluating and investigating unexplained anaemia in older
people and that endocrine causes should be considered. Osteoporosis also requires evaluation with secondary
causes considered.
Introduction
Unexplained anaemia is a rare mode of presentation for
prolactinoma. We describe a 70-year-old man whose
diagnosis of prolactinoma was not revealed until after
six years. During the initial evaluation, his anaemia was
ascribed to old age. However, after six years, prolacti-
noma was diagnosed and subsequently successfully trea-
ted with cabergoline, thus reversing his anaemia and its
symptoms.
Case presentation
A 70-year-old Caucasian man with mild chronic anae-
mia and tiredness was referred to the haematology. Six
years before, he had been referred to secondary care. At
the time of the initial assessment, he was noted to have
a normochromic normocytic anaemia with a haemoglo-
bin (Hb) of 109 g/L, mean corpuscular volume 84fL,
platelet count 307 × 10
9/L, and white cell count (WCC)
of 7.9 × 10
9/L with a normal differential. Serum vitamin
B12, red cell folate and iron studies were normal.
Despite this, he was investigated with an upper gastroin-
testinal endoscopy, sigmoidoscopy, barium enema and
abdominal ultrasound - all of which were normal. Endo-
crine causes for the anaemia were not considered. The
anaemia was ascribed to old age. He was not followed
up but he presented to primary care six years later with
ongoing tiredness. He was found to have a mild anaemia
(Hb 118 g/L, WCC 5.6 × 10
9/L, platelets 330 × 10
9/L).
Because of his anaemia and tiredness, it was decided
that he be referred to haematology. Haematology review
showed that the blood film of our patient was normo-
chromic and normocytic and that serum vitamin B12,
red cell folate, iron studies, liver function tests, routine
biochemistry and serum protein electrophoresis were all
normal. During clinic review, direct questions revealed
that our patient had already noticed the gradual onset
of sparse body hair with loss of libido and erections six
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He had ascribed these changes to his age and considered
them unimportant. Further questioning revealed that in
the year prior to the haematology review he had frac-
tured his left radius on two separate occasions with
minimal trauma. On examination, he appeared pale with
sparse axillary and pubic hair with no galactorrhoea or
gynaecomastia. On neurological examination there were
no visual field defects or cranial nerve abnormalities.
The serum prolactin was 31000 mIU/L (20-300), lutei-
nising hormone (LH) 0.3 IU/L (2-9), follicle stimulating
hormone (FSH) 0.6IU/L (2-9) and testosterone 0.8
nmol/L (8 -38). The random cortisol was 237 nmol/L
with a cortisol of 540 nmol/L 1hour post intramuscular
injection with 250 μg of tetracosactrin. Insulin-like
growth factor was 60 μg/L (58-227). The thyroid stimu-
lating hormone was 1.65 mU/L (0.25-2.5) and free thyr-
oxine index 37 (55-160). Pituitary MRI demonstrated a
pituitary mass (20 mm vertically) consistent with a
macroadenoma. Formal perimetry revealed no visual
field defect. Bone mineral density (evaluated by dual X-
ray absorptiometry) confirmed osteoporosis (t score L2-
L4 -2.9 standard deviations, t score right neck of femur
-3.1 standard deviations). Our patient was commenced
on cabergoline rising to a dose of 2 mg weekly. After
one year, he continued with 2 mg of cabergoline weekly.
Six months after starting cabergoline, his Hb had risen
to 126 g/L. A year after commencing cabergoline, his
prolactin fell to 923 mIU/L and his Hb rose to 137 g/L
with a dissipation of his symptoms.
Discussion
The clinical presentation of prolactinoma depends on
patient’s age, gender and duration of hyperprolactinae-
mia [1]. Women of reproductive age tend to present
with menstrual disturbance, infertility, delayed menarche
or galactorrhoea. Loss of libido, impotence (partial or
complete) and infertility are possible presenting features
in younger males [1]. Hyperprolactinaemia can create a
hypogonadic state [2] which is associated with anaemia.
However, an unexplained anaemia is a rare mode of pre-
sentation for prolactinoma. In the case described above,
the mild anaemia was extensively investigated during his
first presentation. But endocrine causes were not con-
sidered or tested for, and anaemia was merely ascribed
to old age. Six years later, the anaemia was resolved
when the prolactin levels were reduced, making it rea-
sonable to deduce that hyperprolactinaemia was the
cause of the anaemia all along.
It is believed that hyperprolactinaemia impairs pulsa-
tile gonadotrophin (LH and FSH) release by interfering
with hypothalamic gonadotrophin releasing hormone
secretion [1]. The resulting hypogonadism, with reduced
serum testosterone, is reversible with the reduction of
prolactin secretion [2]. Hypogonadism may also be
caused by a direct pressure effect from an enlarging pro-
lactinoma in the context of a hypopituitary state. Andro-
gens stimulate erythropoeisis, at least in part, by
increasing levels of erythropoetin [3]. During puberty,
the male haemoglobin concentration rises above that of
the female which is not related to iron deficiency, preg-
nancy or blood loss [3]. Osteoporosis is also a well-
recognised complication of prolonged hypogonadism in
men [4,5]. Slightly lower haemoglobin values may be
encountered by very old people [6], who have been
thought to present a physiological response of senes-
cence [7]. However, they are not statistically significant.
Healthy older men and women should have haematolo-
gical values similar to younger adults [6]. Our patient
was at the age when complaints of sexual dysfunction
are rare, unless symptoms are directly sought in them.
Presentation of prolactinoma in the elderly persons may
simply be as anaemia and tiredness with or without
osteoporosis.
Conclusion
Anaemia in the elderly people should be fully evaluated,
with endocrine causes considered. Symptoms of hypogo-
nadism may not be found unless directly sought. Osteo-
porosis may be secondary in origin and this should be
kept in mind when assessing patients of all ages. In the
older person, prolactinoma may present insidiously as a
chronic anaemia and hypogonadism with or without
osteoporosis.
Consent
At the time of the diagnosis, written informed consent
was gained from our patient for publication of this case
report. Every effort was made to gain up to date consent
from our patient for this publication but this has not
been possible. The identity of our patient will remain
anonymous, making publication possible without con-
temporaneous consent.
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